APA

Konrad C., Kawamata H., Bredvik K. G., Arreguin A. J., Cajamarca S. A., Hupf J. C., Ravits J. M., Miller T. M., Maragakis N. J., Hales C. M., Glass J. D., Gross S., Mitsumoto H. & Manfredi G. (20180724). Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. : Molecular neurodegeneration.

Chicago

Konrad Csaba, Kawamata Hibiki, Bredvik Kirsten G, Arreguin Andrea J, Cajamarca Steven A, Hupf Jonathan C, Ravits John M, Miller Timothy M, Maragakis Nicholas J, Hales Chadwick M, Glass Jonathan D, Gross Steven, Mitsumoto Hiroshi and Manfredi Giovanni. 20180724. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. : Molecular neurodegeneration.

Harvard

Konrad C., Kawamata H., Bredvik K. G., Arreguin A. J., Cajamarca S. A., Hupf J. C., Ravits J. M., Miller T. M., Maragakis N. J., Hales C. M., Glass J. D., Gross S., Mitsumoto H. and Manfredi G. (20180724). Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. : Molecular neurodegeneration.

MLA

Konrad Csaba, Kawamata Hibiki, Bredvik Kirsten G, Arreguin Andrea J, Cajamarca Steven A, Hupf Jonathan C, Ravits John M, Miller Timothy M, Maragakis Nicholas J, Hales Chadwick M, Glass Jonathan D, Gross Steven, Mitsumoto Hiroshi and Manfredi Giovanni. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. : Molecular neurodegeneration. 20180724.